Collex
3D printed all-marine hydrogel wound dressing
®
REG212
Wound healing
HTX from salmon roe• Advanced wound dressing• Medical device class III
Feasibility
Pre-Clinical
Pivotal
Discovery
Collex® is an advanced hydrogel wound dressing containing HTX™ salmon roe extract.
Collex® is currently in the late pre-clincial stage, with demonstrated significant beneficial effects on wound healing rates.
The development of Collex® is led by Regenics, with joint support from a.o. RISE AB (Sweden) and Scantox A/S (Denmark). The project is supported by a 17.3 mill NOK grant from the EU BlueBio Cofund.
Collex® is tentatively designated as a Medical Device, class III. The company intends to market the device in the US, European and other large markets.
The development of Collex® is led by Regenics, with joint support from a.o. RISE AB (Sweden) and Scantox A/S (Denmark). The project is supported by a 17.3 mill NOK grant from the EU BlueBio Cofund.
Collex® is tentatively designated as a Medical Device, class III. The company intends to market the device in the US, European and other large markets.
Collex® is a 3D bioprinted advanced wound dressing designed to aid healing of partial thickness burns and chronic wounds, including diabetic and chronic vascular ulcers. With Collex®, Regenics aims to redefine the current standards of care in wound treatment.
Collex® is constructed with all-marine ingredients, sourced from the Norwegian coast. The patch is consists of alginate from brown algae, nanocellulose from tunicates, and HTX™, our proprietary salmon roe extract.
Collex® is constructed with all-marine ingredients, sourced from the Norwegian coast. The patch is consists of alginate from brown algae, nanocellulose from tunicates, and HTX™, our proprietary salmon roe extract.
A quick summary of Collex®
Natural ingredients
A 3D printed all-marine advanced wound healing device.
HTX™ from salmon roe
Indication
Burns and chronic wounds
Stage
Late pre-clinical
- Fourth most common type of trauma globally
- Often painful and slow to heal
- Characterized by excessive inflammation
- May cause significant scarring, disfigurement and disability
Facts on burn injuries
- Combines qualities of many current standard-of-care products
- Contains HTX™ to facilitate the unique healing properties of salmon roe
- Faster wound closure with less complications
- Reduction of inflammation, pain and scarring
Potential advantages of Collex®
Vernex® is an HTX™-based hydrogel wound spray, intended for treatment of partial thickness burns and chronic wounds.
WoundClear™ is a novel drug derived from trout LCE, intended for enzymatic wound debridement.
Other products
Oslo Science Park
Gaustadalléen 21
0349 Oslo
Gaustadalléen 21
0349 Oslo
Org. nr. 982 277 086